Biopsy-driven treatment strategy improves clinical outcomes in psoriatic arthritis
The management of psoriatic arthritis is increasingly focused on the early identification of clinical, immunological, and tissue-based phenotypes…
Why exercise matters for obesity even when the scale barely moves
A new American Heart Association scientific statement finds that exercise does far more than help shed pounds, improving…
Weight-loss drugs may cut breast cancer risk by up to 30%, study finds
Women who take GLP-1 medications, such as Ozempic or Mounjaro, are less likely to develop breast cancer, a…
Real-world study exposes suboptimal adherence to treat-to-target rheumatic strategies
EULAR – The European Alliance of Associations for Rheumatology – acknowledges the role of diverse real-world data to…
Forget Zepbound: Eli Lilly’s Next Billion-Dollar Weight-Loss Drug May Be Even Better
Eli Lilly (NYSE: LLY) has been posting incredible sales and earnings growth in recent quarters, thanks in no…
Could GLP-1 drugs help prevent breast cancer? New study points to a possible link
A major breast imaging study links GLP-1 agonists to lower breast cancer incidence, raising hopes for a new…
What really helps with weight loss? New study points to a surprising factor
Anyone trying to lose weight is well acquainted with the plethora of recommendations: Less carbohydrates, more protein, more…
Bariatric surgery improves long-term ability to manage household tasks
People who undergo bariatric surgery and see substantial weight loss are better able to cope with household tasks…
An experimental GLP-1 pushes the limits of weight loss. There are risks.
Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity…
Have We Gotten Calories Wrong All This Time? Study Challenges 130 Years Of Nutrition Science
(© Mark Poprocki – stock.adobe.com) Your Gut Bacteria Change How Many Calories Your Body Actually Absorbs. A New…
GLP-1s are fueling a rise of a bizarre, rare ear disorder
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…
Fitness trainer with 18 years of experience explains why slow weight loss is more sustainable for long term results
When it comes to weight loss, quick results are often the goal – which is why many people…